Abstract
The efficacy of lung cancer immunotherapy with immune check inhibitors is well documented in clinical trials and in real life. However response to this therapy is individual and the biomarkers are continually investigated. The character of local tumour environment seems to be not without significance. We previously presented the usefulness of BAL in the evaluation of immune status of NSCLC patients. The aim of this study was to present the results of immune cells analysis in lymph nodes (LNs) aspirates obtained by EBUS/TBNA. 36 patients with primary lung cancer were investigated- an additional aspirate was taken for analysis by EBUS/TBNA during diagnostic bronchoscopy. The proportion of immune cells were determined in LNs aspirates and, for comparison, in peripheral blood (PB) by multiparameter flow cytometry. A panel of monoclonal antibodies was used for detection of: CD3, CD4, CD8 cells, NKT, NK, dendritic cells (DCs), regulatory Tcells (Tregs) and the expression of PD-1 and PD-L1 on lymphocytes and DCs. We found significant differences in the proportion of the main types of lymphocytes and dendritic cells between LNs aspirates and PB- the proportion of cells was higher in LNs than in PB and was highest in metastatic LNs (Table). Statistical analysis revealed important correlations between regulatory immune cells in metastatic lymph nodes. This may be evidence of consistent immune response in this local microenvironment. Significant differences (Mann Whitney test) in the proportion of immune cells in the blood (PB) and LNs.Table: 177PCellsPBLNsP<0.05CD317.2528.45*CD410.0516.10*CD86.859.95NKT0.100.80*NK2.353.35DCs0.040.71*PDL-1+ DCs1.6458.65*PD-1+ DCs1.8240.51*PD-1+ T cells10.4125.02*Dregs0.2222.50*Effector T cells2.405.80*Th1727.4534.15Tregs0.301.15 Open table in a new tab The results of this study confirmed the advantage of immune cells analysis in LNs aspirates obtained by EBUS/TBNA in the same time during lung cancer diagnosis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
